PubMed ID:
33684933
Public Release Type:
Journal
Publication Year: 2021
Affiliation: ZS, Princeton, New Jersey, USA.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma AG, Basel, Switzerland.; ZS, Princeton, New Jersey, USA.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharma AG, Basel, Switzerland.; Novartis Pharmaceuticals Inc, East Hanover, USA.; Novartis Pharma AG, Basel, Switzerland.; Metabolic Liver Research Program. I. Department of Medicine, University Medical Center, Mainz, Germany.
DOI:
https://doi.org/10.1093/jamia/ocab003
Authors:
Docherty Matt, Regnier Stephane A, Capkun Gorana, Balp Maria-Magdalena, Ye Qin, Janssens Nico, Tietz Andreas, Löffler Jürgen, Cai Jennifer, Pedrosa Marcos C, Schattenberg Jörn M
Request IDs:
21817
Studies:
Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database
To develop a computer model to predict patients with nonalcoholic steatohepatitis (NASH) using machine learning (ML).